Metastatic Non-Small Cell Lung Cancer

mNSCLC Video Perspectives

Healio spoke with experts in lung cancer about recent advances in mNSCLC treatment, designer therapies and more.

Rohit Kumar, MD

Rohit Kumar, MD, associate professor and director of the Respiratory and Pulmonary Function Service at Fox Chase Cancer Center and Lung Cancer Screening Panel member with National Comprehensive Cancer Network, spoke with Healio about the role pulmonologists play in the care continuum of metastatic non-small cell lung cancer.

In this video series, Kumar discussed:

  • The advantages of co-management of patients with metastatic NSCLC between the pulmonologist and oncologist;
  • How pulmonologists tend to be “the first person that metastatic non-small cell lung cancer patients would see,” and how to “expedite” care by ordering biomarker testing at the same time as biopsies are being scheduled;
  • Taking care of patients with metastatic NSCLC who are being treated with immunotherapy;
  • The role of the pulmonologist in the care of patients with metastatic NSCLC who are being treated with targeted therapy; and
  • How COVID has impacted the care of patients with metastatic NSCLC.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.